These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease. Akinci D, Turkbey B, Yilmaz R, Akpinar E, Ozmen MN, Akhan O. Cardiovasc Intervent Radiol; 2008; 31(5):926-30. PubMed ID: 18196333 [Abstract] [Full Text] [Related]
5. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics. Suwabe T, Araoka H, Ubara Y, Kikuchi K, Hazue R, Mise K, Hamanoue S, Ueno T, Sumida K, Hayami N, Hoshino J, Imafuku A, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K. Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1369-79. PubMed ID: 25851811 [Abstract] [Full Text] [Related]
6. A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection. Akihisa T, Ino A, Egawa H, Kotera Y, Ariizumi S, Oomori A, Yamashita S, Yamamoto Y, Tsuchiya K, Yamamoto M, Nitta K, Mochizuki T. CEN Case Rep; 2018 Nov; 7(2):307-312. PubMed ID: 29956096 [Abstract] [Full Text] [Related]
20. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Hiyama L, Tang A, Miller LG. Am J Kidney Dis; 2006 Jan; 47(1):e9-13. PubMed ID: 16377378 [Abstract] [Full Text] [Related] Page: [Next] [New Search]